Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study
GLAUDIA is a glaucoma diagnostic and imaging study sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS; the trial statu…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Optimal Treatment Protocol for Selective Laser Trabeculoplasty [NA]
This clinical trial update describes the status of a study evaluating the optimal treatment protocol for selective laser trabeculoplasty in …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Clarifying the Optimal Application of SLT Therapy Trial [Phase 3]
Phase 3 trial evaluating the optimal use of selective laser trabeculoplasty (SLT) therapy for glaucoma and ocular hypertension is currently …
-
FDA approval · 2025-10-01FDA Approved: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for dorzolamide hydrochloride ophthalmic solution from Micro Labs Limited.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial [NA]
This clinical trial update describes a repeat study to optimize the treatment protocol for selective laser trabeculoplasty in glaucoma. The …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-09-22FDA Approved: BIMATOPROST — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for bimatoprost from Amneal Pharmaceuticals NY LLC, enabling a generic version of the ophthalmic thera…
-
FDA approval · 2025-09-18FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for ALPHAGAN P (brimonidine tartrate) from Allergan, Inc., regarding labeling changes. The product i…
-
FDA approval · 2025-09-18FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) submitted by Allergan, Inc.
-
FDA approval · 2025-09-09FDA Approved: ZOLYMBUS — Original Application (Thea Pharma Inc.)
FDA approved ZOLYMBUS (bimatoprost) from Thea Pharma Inc. under NDA217307 as an ocular hypotensive agent to lower intraocular pressure in ad…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial comparing NCX-470 to latanoprost in open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma [NA]
A completed clinical trial evaluated the safety and effectiveness of the Bimatoprost Implant System used in combination with an intraocular …
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination
An observational study evaluating long-term outcomes for patients with glaucoma, ocular hypertension, or cataracts treated with the SpyGlass…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Long-term Safety and Efficacy Extension Trial of Bimatoprost SR [Phase 3]
Phase 3 long-term safety and efficacy extension trial of Bimatoprost SR for open-angle glaucoma and ocular hypertension; current status is a…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 study assessing safety and efficacy of H-1337 in subjects with primary open-angle glaucoma or ocular hypertension has completed, wit…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluates the Bimatoprost Implant System used with a SpyGlass intraocular lens, comparing it to Timolol …
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial update evaluating the duration of effect of Bimatoprost SR in participants with open-angle glaucoma or ocular hyperte…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on Glaucoma
This clinical trial update describes a study assessing the relationship between limbal function and tear proteomics in chronic ocular diseas…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: iCare IC1000 Alignment Study [NA]
The iCare IC1000 Alignment Study for intraocular pressure by Icare Finland Oy has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
An 18-month prospective efficacy and safety study of the bimatoprost intracameral implant (DURYSTA) for open-angle glaucoma and ocular hyper…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes. [NA]
This clinical trial update notes that the follow-up extension study for the MINT procedure to monitor long-term intraocular pressure reducti…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty [NA]
This update reports the completion of a clinical study evaluating an automated laser device for direct selective laser trabeculoplasty in op…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
A prospective trial is evaluating Direct Selective Laser Trabeculoplasty (DSLT) for achieving >20% intraocular pressure reduction without me…
-
CLINICAL_TRIALS withdrawal · 2025-07-11Clinical Trial Update: An Observational Study to Evaluate the ETX-4143 Device in Subjects With Ocular Hypertension
The registry entry indicates the observational study evaluating the ETX-4143 device for ocular hypertension has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT [Phase 4]
Phase 4 clinical trial update evaluating Rhopressa (netarsudil) for lowering intraocular pressure in adults with primary open-angle glaucoma…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Transscleral Selective Laser Trabeculoplasty Project [NA]
Clinical trial update for a transscleral selective laser trabeculoplasty project, currently recruiting. The study involves open-angle glauco…